The High Stakes of Heart Damage in Aortic Stenosis Treatment
A major meta-analysis in Heart reveals that advanced cardiac damage significantly worsens outcomes for patients undergoing transcatheter aortic valve implantation (TAVI) for severe aortic stenosis. The study, synthesizing data from 34 studies and over 26,000 patients, found that the presence of right ventricular dysfunction, pulmonary hypertension, and tricuspid regurgitation—collectively staged using the Généreux system—is a powerful predictor of mortality and rehospitalization. Hazard ratios for all-cause mortality at 12 months rose sharply with each stage of damage, from 1.61 for borderline cases to 2.77 for the most severe stage 4 disease. The findings underscore that the risk associated with aortic stenosis is a continuous spectrum of cardiac injury, extending far beyond the valve itself.
Study Significance: For cardiologists and heart teams, this research provides a robust, evidence-based framework for pre-TAVI risk stratification, moving beyond traditional surgical scores. Integrating a formal assessment of extravalvular cardiac damage into clinical workflow can directly inform patient selection, procedural planning, and post-operative management strategies. This shift enables more personalized counseling and could guide targeted interventions to manage pulmonary hypertension or right ventricular dysfunction before valve replacement, potentially improving survival rates and reducing costly hospital readmissions.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
